journal article·2022-10

Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer

Xijuan Yao, Shuting Lu, Cheng Feng, Ruiyang Suo, Hang Li, Yi Zhang, Qi Chen, Jian Lu, Bo Wu, Jinhe Guo

Biomaterials· Volume 289
Publisher page

Abstract

Iodine-125 (125I) brachytherapy has become one of the most effective palliative treatment options for advanced esophageal cancer. However, resistance toward 125I brachytherapy caused by pre-existing tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) signaling pathway activation represents a significant limitation in esophageal cancer treatment. To circumvent these problems, herein, we proposed an innovative strategy to alleviate radioresistance of brachytherapy by co-encapsulating catalase (CAT) and HIF-1 inhibitor-acriflavine (ACF) into the hydrophilic cavities of liposome, termed as "ACF-CAT@Lipo". Under overexpressed H2O2 stimulation in the tumor region, the fabricated ACF-CAT@Lipo can generate an amount of O2 and alleviate tumor hypoxia in vitro and in vivo. Furthermore, cooperating with ACF, the expression of hypoxia-related protein (e.g. HIF-1α, VEGF, MMP-2) are obviously decreased. Importantly, the copious oxygenation and the significant inhibition expression of HIF-1α can further improve the radiosensitivity of 125I brachytherapy and finally realize the eradication of esophageal cancer in vivo. The oxygen enrichment and HIF-1 inhibition function of ACF-CAT@Lipo provides a new strategy to overcome the brachytherapy resistance of esophageal cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. Cachexia in patients with oesophageal cancer10.1038/nrclinonc.2015.200 ↗
2. Advances in the curative management of oesophageal cancer10.1038/s41416-021-01485-9 ↗
3. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study10.1111/j.1442-2050.2011.01248.x ↗
4. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial10.1016/S1470-2045(14)70131-7 ↗
5. Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer10.2967/jnumed.107.046474 ↗
6. The relative biological effectiveness of photon radiation from encapsulated iodine-125, assessed in cells of human origin: I. Normal diploid fibroblasts10.1016/0360-3016(90)90315-B ↗
7. Functionalized selenium nanosystem as radiation sensitizer of (125)I seeds for precise cancer therapy10.1021/acsami.7b07167 ↗
8. Lobaplatin promotes (125)I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway10.1038/s41419-019-1918-1 ↗
9. A robust oxygen microbubble radiosensitizer for iodine-125 brachytherapy10.1002/advs.202002567 ↗
10. Overcoming radioresistance in tumor therapy by alleviating hypoxia and using the HIF-1 inhibitor10.1021/acsami.9b18633 ↗
11. Tumor microenvironment as A "game changer" in cancer radiotherapy10.3390/ijms20133212 ↗
12. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
13. Exploiting tumour hypoxia in cancer treatment10.1038/nrc1367 ↗
14. Hypoxia and radiation therapy: past history, ongoing research, and future promise10.2174/156652409788167087 ↗
15. Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy10.1016/j.nantod.2020.100960 ↗
16. High intensity focused ultrasound-responsive and ultrastable cerasomal perfluorocarbon nanodroplets for alleviating tumor multidrug resistance and epithelial-mesenchymal transition10.1021/acsnano.0c07287 ↗
17. Genetically modified bacteria for targeted phototherapy of tumor10.1016/j.biomaterials.2021.120809 ↗
18. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma
19. Catalase-based liposomal for reversing immunosuppressive tumor microenvironment and enhanced cancer chemo-photodynamic therapy10.1016/j.biomaterials.2020.119755 ↗
20. Fluorinated chitosan-mediated intracellular catalase delivery for enhanced photodynamic therapy of oral cancer10.1039/D0BM01898H ↗
21. Smart" delivery of monoclonal antibodies from a magnetic responsive microgel nanocomposite10.1021/acsabm.1c00994 ↗
22. Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation10.1021/acsnano.9b06689 ↗
23. Repurposing of acriflavine to target chronic myeloid leukemia treatment10.2174/0929867327666200908114411 ↗
24. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan10.1016/j.canlet.2016.09.029 ↗
25. Ferric ion driven assembly of catalase-like supramolecular photosensitizing nanozymes for combating hypoxic tumors10.1002/anie.202010005 ↗
26. A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro10.1259/bjr.74.877.740056 ↗
27. Catalase-loaded TaOx Nanoshells as bio-Nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy10.1002/adma.201602111 ↗
28. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization10.1073/pnas.0909353106 ↗
29. VEGF in signaling and disease: beyond discovery and development10.1016/j.cell.2019.01.021 ↗
30. New functions for the matrix metalloproteinases in cancer progression10.1038/nrc745 ↗
31. Iodine-125 seed radiation induces ROS-mediated apoptosis, autophagy and paraptosis in human esophageal squamous cell carcinoma cells
32. Combined strategy of radioactive I seeds and salinomycin for enhanced glioma chemo-radiotherapy: evidences for ROS-mediated apoptosis and signaling crosstalk10.1007/s11064-018-2547-2 ↗
33. Chloroquine reverses chemoresistance via upregulation of p21 and autophagy inhibition in ovarian cancer10.1038/s41419-020-03242-x ↗
34. Genetic screen for cell fitness in high or low oxygen highlights mitochondrial and lipid metabolism10.1016/j.cell.2020.03.029 ↗
35. Adhesion-mediated apoptosis resistance in cancer10.1016/j.drup.2009.08.001 ↗
36. Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer10.1007/978-3-030-12734-3_5 ↗
37. The protective roles of ROS-mediated mitophagy on (125)I seeds radiation induced cell death in HCT116 cells10.1155/2016/9460462 ↗
38. 125)I seeds radiation induces paraptosis-like cell death via PI3K/AKT signaling pathway in HCT116 cells10.1155/2016/8145495 ↗